CLINICAL_TRIALS
trial_result
· 2017-06-06
Clinical Trial Update: Thalidomide in Treating Patients With Thyroid Cancer [Phase 2]
Summary
Thalidomide was evaluated in a Phase 2 trial for thyroid cancer, and the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kenneth Ain | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED